Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2000 1
2002 1
2004 1
2005 2
2006 1
2007 1
2008 2
2009 3
2010 2
2013 6
2014 8
2015 9
2016 12
2017 11
2018 5
2019 11
2020 7
2021 10
2022 10
2023 7
2024 16
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Sanqi oral solution ameliorates renal fibrosis by suppressing fibroblast activation via HIF-1alpha/PKM2/glycolysis pathway in chronic kidney disease.
Hu D, Wang L, Zhang Y, Liu X, Lu Z, Li H. Hu D, et al. J Ethnopharmacol. 2024 Dec 5;335:118679. doi: 10.1016/j.jep.2024.118679. Epub 2024 Aug 8. J Ethnopharmacol. 2024. PMID: 39121930 Free article.
ETHNOPHARMACOLOGICAL RELEVANCE: Sanqi oral solution (SQ) is a traditional Chinese patent medicine, widely used to treat chronic kidney diseases (CKD) in the clinic in China. ...
ETHNOPHARMACOLOGICAL RELEVANCE: Sanqi oral solution (SQ) is a traditional Chinese patent medicine, widely used to treat chronic kidne …
Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway.
Zhao M, Feng L, Li W. Zhao M, et al. Drug Des Devel Ther. 2024 Oct 9;18:4529-4550. doi: 10.2147/DDDT.S480248. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39399124 Free PMC article.
OBJECTIVE: To employee network pharmacology to predict the components and pathways of SanQi-DanShen (SQDS) in treating coronary heart disease, followed by in vitro experiments to validate the molecular mechanism of SQDS in treating coronary heart disease. ...
OBJECTIVE: To employee network pharmacology to predict the components and pathways of SanQi-DanShen (SQDS) in treating coronary heart …
Sanqi Qushi formula ameliorates renal injury in experimental membranous nephropathy rats by inhibiting the MEK/ERK signaling pathway.
Lin Z, Wang Z, Kim Thuong VP, Zhang X, Liang B, Li M, Li M, Duan T, Li Z, Li P, Wu A, Yang J, Bao K, Liu B. Lin Z, et al. J Ethnopharmacol. 2025 May 28;348:119813. doi: 10.1016/j.jep.2025.119813. Epub 2025 Apr 14. J Ethnopharmacol. 2025. PMID: 40239880
ETHNOPHARMACOLOGICAL RELEVANCE: Sanqi Qushi Formula (SQQS), a clinically validated derivative of the Sanqi oral solution, integrates principles of traditional Chinese medicine (TCM) to treat membranous nephropathy (MN). ...
ETHNOPHARMACOLOGICAL RELEVANCE: Sanqi Qushi Formula (SQQS), a clinically validated derivative of the Sanqi oral solution, inte …
Safflower yellow pigment and Sanqi Panax notoginseng in the treatment of acute cerebral infarction: a systematic review, meta-analysis, and cost-effectiveness analysis.
Li Y, Lin Y, Shi Z, Hu Y, Shao T, Li M, Zhu J, Sun L, Chang F. Li Y, et al. Ann Transl Med. 2021 Sep;9(18):1407. doi: 10.21037/atm-21-782. Ann Transl Med. 2021. PMID: 34733959 Free PMC article.
From the perspective of pharmacoeconomics, compared with Sanqi Panax notoginseng group, the ICER of safflower yellow injection is 3,885.75 RMB. ...It is also more cost-effective than the use of Sanqi Panax notoginseng injection....
From the perspective of pharmacoeconomics, compared with Sanqi Panax notoginseng group, the ICER of safflower yellow injection is 3,8 …
Production and pharmaceutical research of minor saponins in Panax notoginseng (Sanqi): Current status and future prospects.
Zhang H, Li J, Diao M, Li J, Xie N. Zhang H, et al. Phytochemistry. 2024 Jul;223:114099. doi: 10.1016/j.phytochem.2024.114099. Epub 2024 Apr 18. Phytochemistry. 2024. PMID: 38641143 Review.
Chen is a traditional medicinal herb known as Sanqi or Tianqi in Asia and is commonly used worldwide. It is one of the main raw ingredients of Yunnan Baiyao, Fu fang dan shen di wan, and San qi shang yao pian. ...
Chen is a traditional medicinal herb known as Sanqi or Tianqi in Asia and is commonly used worldwide. It is one of the main raw ingre …
Pre-treatment with notoginsenoside R1 from Panax notoginseng protects against high-altitude-induced pulmonary edema by inhibiting pyroptosis through the NLRP3/caspase-1/GSDMD pathway.
Huang D, Wang Y, Pei C, Zhang X, Shen Z, Jia N, Zhao S, Li G, Wang Z. Huang D, et al. Biomed Pharmacother. 2024 Nov;180:117512. doi: 10.1016/j.biopha.2024.117512. Epub 2024 Sep 30. Biomed Pharmacother. 2024. PMID: 39353320 Free article.
Notoginsenoside R1 (NGR1), a major active constituent of Panax notoginseng (Burkill) F.H.Chen (sanqi), has demonstrated heart and lung-protective effects under hypobaric hypoxia. However, there is a lack of clarity regarding the precise mechanisms that underlie the protect …
Notoginsenoside R1 (NGR1), a major active constituent of Panax notoginseng (Burkill) F.H.Chen (sanqi), has demonstrated heart and lun …
Combinatorial metabolism notably affects human systemic exposure to ginsenosides from orally administered extract of Panax notoginseng roots (Sanqi).
Hu Z, Yang J, Cheng C, Huang Y, Du F, Wang F, Niu W, Xu F, Jiang R, Gao X, Li C. Hu Z, et al. Drug Metab Dispos. 2013 Jul;41(7):1457-69. doi: 10.1124/dmd.113.051391. Epub 2013 May 6. Drug Metab Dispos. 2013. PMID: 23649704
Ginsenosides are medicinal ingredients of the cardiovascular herb Panax notoginseng roots (Sanqi). Here, we implemented a human study (ChiCTR-ONC-09000603; www.chictr.org) to characterize pharmacokinetics and metabolism of ginsenosides from an orally ingested Sanqi- …
Ginsenosides are medicinal ingredients of the cardiovascular herb Panax notoginseng roots (Sanqi). Here, we implemented a human study …
Sanqi Qushi Granule Alleviates Proteinuria and Podocyte Damage in NS Rat: A Network Pharmacology Study and in vivo Experimental Validation.
Wang L, Liu H, Wang Y, Hong X, Huang X, Han M, Wang D, Shan W, Li P, Gu H, Liu B, Bao K. Wang L, et al. Drug Des Devel Ther. 2023 Jun 19;17:1847-1861. doi: 10.2147/DDDT.S403617. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37360573 Free PMC article.
BACKGROUND: Nephrotic syndrome (NS) and its numerous complications remain the leading causes of morbidity and mortality globally. Sanqi Qushi granule (SQG) is clinically effective in NS. However, its potential mechanisms have yet to be elucidated. ...
BACKGROUND: Nephrotic syndrome (NS) and its numerous complications remain the leading causes of morbidity and mortality globally. Sanqi …
PanaxGDB: A Comprehensive Platform for Panax.
Lin Y, Hao B, Lu YC, Dong Y, Li Y, Zhang GH, Yang ZJ, Xiang GS, Liu GZ, Li XJ, Zhu Q, Yang QH, Li XZ, Yang SC. Lin Y, et al. Front Plant Sci. 2022 May 25;13:883818. doi: 10.3389/fpls.2022.883818. eCollection 2022. Front Plant Sci. 2022. PMID: 35693187 Free PMC article.
In past decades, molecular biotechnology and breeding techniques have been respectively used to generate omics data and information on cultivars primarily from Panax ginseng (ginseng), Panax quinquefolium (American ginseng), and Panax notoginseng (Sanqi) to biosynthesize v …
In past decades, molecular biotechnology and breeding techniques have been respectively used to generate omics data and information on culti …
120 results